AzTrials
AzTrials

Research institution

Capital Medical University Clinical Trials

Studies where Capital Medical University is the lead sponsor: what is enrolling now, by phase, condition and country.

333 registered studies

In numbers

Open to volunteers
89
Active
95
With results posted
9
All registered
333

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 89
  • Acute Ischemic Stroke

    Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2

    • Recruiting
    • Age: 18 to 80 years
    • Phase 3
    • Surgery or procedure

    This study is a prospective, multicenter, open-label, randomized controlled clinical trial. The investigators will apply albumin to the reperfusion treatment of patients with acute ischemic stroke in the anterior circulation.

    Trial name
    ARISE-2 (NCT07263308)
    Testing
    Albumin, Endovascular treatment
    Where
    61 sites in China
    Volunteers
    1,192 people
    Sponsor
    Capital Medical University
    Can I take part? ARISE-2
  • Pregnancy, Dietary Inflammatory Index (DII)

    Pregnancy Anti-inflammatory Diet Intervention Study

    • Not yet recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    Dietary patterns may influence maternal inflammatory status and pregnancy outcomes. However, structured anti-inflammatory dietary interventions specifically designed for pregnant women remain limited.

    Trial name
    PAID2026 (NCT07890441)
    Testing
    Anti-inflammatory Dietary Intervention
    Where
    China
    Volunteers
    120 people, healthy volunteers welcome
    Sponsor
    Capital Medical University
    Can I take part? PAID2026
  • Influenza, Human

    Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza

    • Not yet recruiting
    • Age: 12 to 65 years
    • Phase 2/3

    The goal of this Phase II/III study is to investigate the safty and efficacy of 102D-6 in adolescents and adults with influenza. The main aim to answer: 1.

    Trial name
    NCT07893847
    Testing
    20 mg 102D-6 dry suspension, 40 mg 102D-6 dry suspension
    Where
    China
    Volunteers
    570 people
    Sponsor
    Capital Medical University
    Can I take part? NCT07893847
  • Respiratory Viral Infections, Influenza

    Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections

    • Not yet recruiting
    • Age: 18 years and older

    The goal of this clinical trial is to evaluate the effects of myxovirus resistance protein A (MxA)-guided antiviral treatment on treatment duration and adverse outcomes in adults hospitalized with influenza or COVID-19, compared…

    Conditions
    Respiratory Viral Infections, Influenza, SARS CoV 2 Infection
    Trial name
    NCT07892872
    Testing
    Baseline MxA testing, Serial MxA testing, MxA result feedback and antiviral treatment recommendations
    Where
    China
    Volunteers
    618 people
    Sponsor
    Capital Medical University
    Can I take part? NCT07892872
  • Mechanical Ventilation

    Titration of PS Guided by FI : A Pilot Study

    • Recruiting
    • Age: 18 years and older
    • Surgery or procedure

    The goal of this single-center, pilot, randomized controlled trial is to evaluate the feasibility and preliminary efficacy of using the Flow Index (FI) to guide Pressure Support (PS) titration in adult patients receiving Pressure…

    Trial name
    NCT07769307
    Testing
    FI-guided ventilator support adjustment, Conventional PS titration
    Where
    China
    Volunteers
    60 people
    Sponsor
    Capital Medical University
    Can I take part? NCT07769307
  • Meningioma, CDK4/6 Inhibitor

    IN10018 in Combination With Dalpiciclib for Progressive Meningiomas

    • Recruiting
    • Age: 18 years and older
    • Phase 1

    This open-label Phase Ib study will evaluate the safety, tolerability, and preliminary effectiveness of IN10018 in combination with dalpiciclib in adults with progressive meningiomas.

    Trial name
    NCT07652762
    Testing
    Ifebemtinib, Dalpiciclib
    Where
    2 sites in China
    Volunteers
    24 people
    Sponsor
    Capital Medical University
    Can I take part? NCT07652762
  • Sarcopenia, Breast Cancer

    Exercise Intervention for Breast Cancer Patients With Sarcopenia

    • Not yet recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    Sarcopenia is a common yet underrecognized complication in breast cancer survivors during rehabilitation, characterized by loss of muscle mass, reduced muscle strength, and impaired physical function, which adversely affects…

    Trial name
    EX-BCSarc (NCT07732101)
    Testing
    "Exercise for Muscle Health" Program
    Where
    China
    Volunteers
    104 people
    Sponsor
    Capital Medical University
    Can I take part? EX-BCSarc
  • Acute Ischemic Stroke

    Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)

    • Recruiting
    • Age: 18 to 80 years
    • Phase 2

    This phase 2, multicenter, randomized, double-blind, placebo-controlled trial will evaluate the efficacy and safety of anisodine hydrobromide in patients with acute ischemic stroke undergoing endovascular thrombectomy.

    Trial name
    NCT07800572
    Testing
    Anisodine Hydrobromide
    Where
    13 sites in China
    Volunteers
    204 people
    Sponsor
    Capital Medical University
    Can I take part? NCT07800572
  • Ischemic Stroke

    Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke

    • Recruiting
    • Age: 18 years and older
    • Phase 3

    This is an investigator-initiated phase III clinical trial employing a randomized, double-blind, placebo-controlled design. The primary objective of this study is to investigate the efficacy and safety of an interleukin-6…

    Trial name
    IRIS-3 (NCT07509645)
    Testing
    Tocilizumab
    Where
    30 sites in China
    Volunteers
    348 people
    Sponsor
    Capital Medical University
    Can I take part? IRIS-3
  • Acute Ischemic Stroke, Cerebral Autoregulation

    Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring

    • Recruiting
    • Age: 18 years and older
    • Medical device
    • Surgery or procedure

    This multicenter, prospective, and interventional diagnostic accuracy study enrolls patients undergoing thrombectomy with intraoperative cerebral autoregulation monitoring and follows them up at predefined time points up to 90…

    Trial name
    FACTOR (NCT07747701)
    Testing
    NIRS-based cerebral oxygenation and blood pressure monitoring, Carotid compression test
    Where
    4 sites in China
    Volunteers
    227 people
    Sponsor
    Beijing Shijitan Hospital, Capital Medical University
    Can I take part? FACTOR

Completed, with results posted

All 9
  • Normobaric Hyperoxia, Intracerebral Hemorrhage

    Normobaric Hyperoxia for Intracerebral Hemorrhage

    • Completed
    • Age: 18 to 80 years
    • Phase 2
    • Medical device
    • Results posted

    Perihematoma edema (PHE), as the major injury for intracranial hemorrhage (ICH) involves more than the initial tissue damage induced directly by the hematoma.

    Trial name
    NCT04144868
    Testing
    Oxygen storage face masks and nasal catheter, Nasal catheter
    Where
    China
    Volunteers
    96 people
    Sponsor
    Capital Medical University
    Can I take part? NCT04144868
  • Periodontitis

    Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis

    • Completed
    • Age: 18 to 70 years
    • Phase 4
    • Pill or oral medicine
    • Results posted

    Chronic periodontitis is an infectious disease of periodontal support tissues caused by bacterial biofilm, which leads to inflammation and destruction of periodontal support tissues ultimately resulting in tooth loss.In the…

    Trial name
    NCT05530252
    Testing
    Oral biological antimicrobial gel, minocycline hydrochloride ointment, SRP
    Where
    China
    Volunteers
    51 people, healthy volunteers welcome
    Sponsor
    Beijing Stomatological Hospital, Capital Medical University
    Can I take part? NCT05530252
  • Chronic Endometritis

    RCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis

    • Completed
    • Age: 18 to 50 years
    • Results posted

    120 cases with a diagnosis of chronic endometritis, confirmed by the presence of plasma cells in endometrial biopsy sample identified by immunohistochemical staining using CD138 antibody, have been recruited.

    Trial name
    NCT02648698
    Testing
    Antibiotics
    Where
    China
    Volunteers
    120 people
    Sponsor
    Fu Xing Hospital, Capital Medical University
  • Normobaric Oxygen, Cerebral Ischemia

    The Efficacy of Normobaric Oxygen on Chronic Cerebral Ischemia

    • Completed
    • Age: 18 to 80 years
    • Medical device
    • Results posted

    Chronic cerebral ischemia (CCI) is viewed as an alarming state induced by long-term reduction in cerebral perfusion, which is associated with neurological deficits and high risk of stroke occurrence or recurrence.

    Trial name
    NCT03745092
    Testing
    normobaric oxygen, room air
    Where
    China
    Volunteers
    49 people
    Sponsor
    Capital Medical University
  • Intrauterine Adhesion

    Postoperative Intermittent Intrauterine Balloon Dilatation Therapy.

    • Completed
    • Age: 18 to 40 years
    • Surgery or procedure
    • Results posted

    In this prospective, randomized, controlled study, the investigators wish to determine the efficacy of intrauterine balloon (IUB) dilatation in the prevention of adhesion reformation when compared with the conventional management.

    Trial name
    NCT03131596
    Testing
    IUB dilatation therapy
    Where
    China
    Volunteers
    200 people
    Sponsor
    Fu Xing Hospital, Capital Medical University
    Can I take part? NCT03131596

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in